WRITE: Written Imaginal Thinking Exercise Study (WRITE)

April 27, 2026 updated by: Nora Barnes-Horowitz, University of Colorado, Boulder

Written Imaginal Thinking Exercise (WRITE) Study

The purpose of the study is to investigate and compare the effects of three different versions of a future imaginal writing exercise (worst-case scenario, neutral future scenario, best-case scenario) for individuals with elevated social anxiety symptoms. Participants (N=270) will be recruited through the online platform, Prolific, and will be randomly assigned to one of three writing exercise conditions. Participants will complete three study sessions across approximately three weeks. Study session 1 (T1) will consist of baseline assessments and pre-writing ratings, a future imaginal writing exercise, and then post-writing ratings. Study session 2 (T2) will occur approximately one week later and will consist of mid-study assessments and pre-writing ratings, a second, repeated future imaginal writing exercise, and then post-writing ratings. Finally, study session 3 (T3) will occur approximately one week later (approximately two weeks after T1) and will consist of follow-up assessments and repeated post-writing ratings.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

270

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Boulder, Colorado, United States, 80309
        • University of Colorado Boulder

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • English fluency
  • Previous high-quality Prolific submission experience
  • Elevated social anxiety symptoms

Exclusion Criteria:

  • Hospitalization for psychiatric reasons within the past year
  • Previous suicide attempt or self-harm
  • Previous treatment for severe head injury or past repeated serious head injury
  • Current psychosis symptoms
  • Elevated trauma symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Worst-Case Scenario
Written exposure exercise about an imagined future worst-case scenario.
Active Comparator: Neutral Future Scenario
Written exercise about an imagined neutral future scenario.
Experimental: Best-Case Scenario
Written exposure exercise about an imagined future best-case scenario.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Phobia Inventory (SPIN)
Time Frame: Baseline through study completion, an average of 3 weeks.
Social anxiety symptom severity, range: 0-68 total, higher scores indicate higher social anxiety symptom severity.
Baseline through study completion, an average of 3 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire (PHQ-8)
Time Frame: Baseline through study completion, an average of 3 weeks.
Depression symptom severity, range: 0-24 total, higher scores indicate higher depression symptom severity.
Baseline through study completion, an average of 3 weeks.
Overall Anxiety Severity and Impairment Scale (OASIS)
Time Frame: Baseline through study completion, an average of 3 weeks.
General anxiety symptom severity, range: 0-20 total, higher scores indicate higher general anxiety symptom severity.
Baseline through study completion, an average of 3 weeks.
Social Approach Motivation
Time Frame: Baseline through study completion, an average of 3 weeks.
Self-reported rating of motivation for social approach over the next week. Rating ranges from 0 (not motivated at all) to 100 (extremely motivated).
Baseline through study completion, an average of 3 weeks.
Positive and Negative Affect Schedule (PANAS-10)
Time Frame: Baseline through study completion, an average of 3 weeks.
Positive and negative affect, range: 5-25 each (total score), higher scores indicate higher positive and negative affect.
Baseline through study completion, an average of 3 weeks.
Cognitive Emotion Regulation Questionnaire (CERQ): Catastrophizing and Positive Reappraisal subscales
Time Frame: Baseline through study completion, an average of 3 weeks.
Use of catastrophizing and positive reappraisal cognitive emotion regulation strategies, range: 1-5 each (average score), higher score reflects higher degree of use of strategy.
Baseline through study completion, an average of 3 weeks.
Threat-related prediction ratings
Time Frame: Baseline through study completion, an average of 3 weeks.
Self-reported ratings of 1) likelihood of feared situation avoidance, 2) likelihood of feared outcome occurrence, 3) predicted intensity of feared outcome occurrence, 4) likelihood of best possible outcome occurrence, and 5) predicted intensity of best possible outcome occurrence. All ratings range from 0 (0% likely/not bad at all/not good at all) to 100 (100% likely/as bad as I can possibly imagine/as good as I can possibly imagine).
Baseline through study completion, an average of 3 weeks.
State emotion ratings
Time Frame: Baseline through study completion, an average of 3 weeks.
Self-reported state ratings of 1) positive affect, and 2) anxiety. All ratings range from 0 (not positive/anxious at all) to 100 (extremely positive/anxious).
Baseline through study completion, an average of 3 weeks.
Writing exercise experience ratings - writing qualities
Time Frame: After each writing exercise, an average of 2 weeks.
Self-reported ratings of vividness/detail and effort of the writing. All ratings range from 0 (not at all) to 100 (extremely), higher scores reflect greater vividness/detail and effort.
After each writing exercise, an average of 2 weeks.
Writing exercise experience ratings - perceived learning
Time Frame: After each writing exercise, an average of 2 weeks.
Self-reported ratings of perceived learning and perspective shift from the writing exercises. All ratings range from 0 (strongly disagree) to 4 (strongly agree). Higher scores reflect greater perceived learning and perspective shift.
After each writing exercise, an average of 2 weeks.
Behavioral approach/avoidance
Time Frame: At the final study session, approximately 3 weeks after Baseline.
Single self-reported rating of willingness to engage in a feared situation. Binary yes/no response, where yes indicates willingness to approach and no indicates avoidance.
At the final study session, approximately 3 weeks after Baseline.
Program feedback ratings - overall
Time Frame: At the final study session, approximately 3 weeks after Baseline.
Ratings assessing overall program feedback (range: 0-28, higher scores reflect more positive overall program feedback).
At the final study session, approximately 3 weeks after Baseline.
Program feedback ratings - perceived benefit
Time Frame: At the final study session, approximately 3 weeks after Baseline.
Rating assessing perceived benefit of the writing exercises (range: 0-4, higher scores reflect higher perceived benefit).
At the final study session, approximately 3 weeks after Baseline.
Program feedback ratings - likelihood of future use
Time Frame: At the final study session, approximately 3 weeks after Baseline.
Rating assessing likelihood of future use of writing exercises (range: 0-100, higher scores reflect higher likelihood of future use).
At the final study session, approximately 3 weeks after Baseline.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

March 2, 2026

First Submitted That Met QC Criteria

March 5, 2026

First Posted (Actual)

March 11, 2026

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 25-0771

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Subscribe